J&J stock jumps after earnings beat, guidance boost
Johnson & Johnson's JNJ) second quarter earnings beat Wall Street's estimates Wednesday, and the company raised its outlook for the year, giving the stock a boost in pre-market trading. The pharma giant reported revenues of $23.7 billion, …